6/29/17
The first phase trial has been completed on the flu vaccine patch. Interesting and promising results were reported in The Lancet. Although more research is necessary and forthcoming, it is an intriguing vaccine delivery alternative.
6/29/17
The first phase trial has been completed on the flu vaccine patch. Interesting and promising results were reported in The Lancet. Although more research is necessary and forthcoming, it is an intriguing vaccine delivery alternative.